首页 > 最新文献

Molecular Metabolism最新文献

英文 中文
Thyroid hormone receptor beta (THRβ1) is the major regulator of T3 action in human iPSC-derived hepatocytes. 甲状腺激素受体 beta(THRβ1)是人类 iPSC 衍生肝细胞中 T3 作用的主要调节因子。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-29 DOI: 10.1016/j.molmet.2024.102057
Lorraine Soares De Oliveira, Joseph E Kaserman, Anne H Van Der Spek, Nora J Lee, Hendrik J Undeutsch, Rhiannon B Werder, Andrew A Wilson, Anthony N Hollenberg

Objective: Thyroid hormone (TH) action is mediated by thyroid hormone receptor (THR) isoforms. While THRβ1 is likely the main isoform expressed in liver, its role in human hepatocytes is not fully understood.

Methods: To elucidate the role of THRβ1 action in human hepatocytes we used CRISPR/Cas9 editing to knock out THRβ1 in induced pluripotent stem cells (iPSC). Following directed differentiation to the hepatic lineage, iPSC-derived hepatocytes were then interrogated to determine the role of THRβ1 in ligand-independent and -dependent functions.

Results: We found that the loss of THRβ1 promoted alterations in proliferation rate and metabolic pathways regulated by T3, including gluconeogenesis, lipid oxidation, fatty acid synthesis, and fatty acid uptake. We observed that key genes involved in liver metabolism are regulated through both T3 ligand-dependent and -independent THRβ1 signaling mechanisms. Finally, we demonstrate that following THRβ1 knockout, several key metabolic genes remain T3 responsive suggesting they are THRα targets.

Conclusions: These results highlight that iPSC-derived hepatocytes are an effective platform to study mechanisms regulating TH signaling in human hepatocytes.

目的:甲状腺激素(TH)的作用是由甲状腺激素受体(THR)同工酶介导的。虽然 THRβ1 可能是肝脏中表达的主要同工酶,但其在人类肝细胞中的作用尚未完全明了:为了阐明THRβ1在人类肝细胞中的作用,我们使用CRISPR/Cas9编辑技术敲除诱导多能干细胞(iPSC)中的THRβ1。在定向分化为肝系后,我们对 iPSC 衍生的肝细胞进行了检测,以确定 THRβ1 在配体依赖性和配体依赖性功能中的作用:结果:我们发现,THRβ1的缺失促进了增殖率和受T3调控的代谢途径的改变,包括葡萄糖生成、脂质氧化、脂肪酸合成和脂肪酸摄取。我们观察到,参与肝脏代谢的关键基因通过依赖于 T3 配体和不依赖于 THRβ1 的信号机制进行调控。最后,我们证明了在THRβ1基因敲除后,几个关键的代谢基因仍然对T3有反应,这表明它们是THRα的靶标:这些结果突出表明,iPSC 衍生的肝细胞是研究人类肝细胞中 TH 信号调节机制的有效平台。
{"title":"Thyroid hormone receptor beta (THRβ1) is the major regulator of T3 action in human iPSC-derived hepatocytes.","authors":"Lorraine Soares De Oliveira, Joseph E Kaserman, Anne H Van Der Spek, Nora J Lee, Hendrik J Undeutsch, Rhiannon B Werder, Andrew A Wilson, Anthony N Hollenberg","doi":"10.1016/j.molmet.2024.102057","DOIUrl":"10.1016/j.molmet.2024.102057","url":null,"abstract":"<p><strong>Objective: </strong>Thyroid hormone (TH) action is mediated by thyroid hormone receptor (THR) isoforms. While THRβ1 is likely the main isoform expressed in liver, its role in human hepatocytes is not fully understood.</p><p><strong>Methods: </strong>To elucidate the role of THRβ1 action in human hepatocytes we used CRISPR/Cas9 editing to knock out THRβ1 in induced pluripotent stem cells (iPSC). Following directed differentiation to the hepatic lineage, iPSC-derived hepatocytes were then interrogated to determine the role of THRβ1 in ligand-independent and -dependent functions.</p><p><strong>Results: </strong>We found that the loss of THRβ1 promoted alterations in proliferation rate and metabolic pathways regulated by T3, including gluconeogenesis, lipid oxidation, fatty acid synthesis, and fatty acid uptake. We observed that key genes involved in liver metabolism are regulated through both T3 ligand-dependent and -independent THRβ1 signaling mechanisms. Finally, we demonstrate that following THRβ1 knockout, several key metabolic genes remain T3 responsive suggesting they are THRα targets.</p><p><strong>Conclusions: </strong>These results highlight that iPSC-derived hepatocytes are an effective platform to study mechanisms regulating TH signaling in human hepatocytes.</p>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":" ","pages":"102057"},"PeriodicalIF":7.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RNA-binding protein YBX3 promotes PPARγ-SLC3A2 mediated BCAA metabolism fueling brown adipogenesis and thermogenesis RNA结合蛋白YBX3促进PPARγ-SLC3A2介导的BCAA代谢,促进棕色脂肪生成和产热。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-29 DOI: 10.1016/j.molmet.2024.102053
Lin-Yun Chen , Li-Wen Wang , Jie Wen , Jing-Dong Cao , Rui Zhou , Jin-Lin Yang , Ye Xiao , Tian Su , Yan Huang , Qi Guo , Hai-Yan Zhou , Xiang-Hang Luo , Xu Feng

Objective

Activating brown adipose tissue (BAT) thermogenesis is a promising approach to combat obesity and metabolic disorders. The post-transcriptional regulation of BAT thermogenesis mediated by RNA-binding proteins (RBPs) is still not fully understood. This study explores the physiological role of novel RBPs in BAT differentiation and thermogenesis.

Methods

We used multiple public datasets to screen out novel RBPs responsible for BAT differentiation and thermogenesis. In vitro loss- and gain-of-function experiments were performed in both C3H10T1/2 preadipocytes and mature brown adipocytes to determine the role of Y-box binding protein 3 (YBX3) in brown adipocyte differentiation and thermogenesis. Adeno-associated virus (AAV)-mediated BAT-specific knockdown or overexpression of Ybx3 was applied to investigate the function of YBX3 in vivo.

Results

YBX3 is a brown adipocyte-enriched RBP induced by cold stimulation and β-adrenergic signaling. Both in vitro loss- and gain-of-function experiments demonstrate that YBX3 is essential for brown adipocyte differentiation and thermogenesis. BAT-specific loss of Ybx3 dampens thermogenesis and exacerbates diet-induced obesity in mice, while overexpression of Ybx3 promotes thermogenesis and confers protection against diet-induced metabolic dysfunction. Transcriptome analysis and mitochondrial stress test indicate that Ybx3 deficiency compromises the mitochondrial oxidative phosphorylation, leading to thermogenic failure. Mechanistically, YBX3 stabilizes the mRNA of Slc3a2 and Pparg, which facilitates branched-chain amino acid (BCAA) influx and catabolism and fuels brown adipocyte differentiation and thermogenesis.

Conclusions

YBX3 facilitates BAT fueling BCAA to boost thermogenesis and energy expenditure, which protects against obesity and metabolic dysfunction. Thus, YBX3 could be a promising therapeutic target for obesity.
目的:激活棕色脂肪组织(BAT)的产热是对抗肥胖和代谢紊乱的一种很有前景的方法。由 RNA 结合蛋白(RBPs)介导的 BAT 产热的转录后调控尚未完全明了。本研究探讨了新型 RBPs 在 BAT 分化和产热过程中的生理作用:方法:我们利用多个公开数据集筛选出负责 BAT 分化和产热的新型 RBPs。我们在C3H10T1/2前脂肪细胞和成熟棕色脂肪细胞中进行了体外功能缺失和功能增益实验,以确定Y-盒结合蛋白3(YBX3)在棕色脂肪细胞分化和产热中的作用。应用腺相关病毒(AAV)介导的BAT特异性Ybx3敲除或过表达研究了YBX3在体内的功能:结果:YBX3是一种富含棕色脂肪细胞的RBP,由冷刺激和β肾上腺素能信号诱导。体外功能缺失和功能增益实验均证明,YBX3 对棕色脂肪细胞的分化和产热至关重要。BAT特异性缺失Ybx3会抑制小鼠的产热并加剧饮食诱导的肥胖,而过表达Ybx3则会促进产热并防止饮食诱导的代谢功能障碍。转录组分析和线粒体压力测试表明,Ybx3 缺乏会损害线粒体氧化磷酸化,导致产热失败。从机制上讲,YBX3能稳定Slc3a2和Pparg的mRNA,从而促进支链氨基酸(BCAA)的流入和分解,并促进棕色脂肪细胞的分化和产热:结论:YBX3 可促进 BAT 为 BCAA 提供燃料,从而促进产热和能量消耗,防止肥胖和代谢功能障碍。因此,YBX3 可作为肥胖症的治疗靶点。
{"title":"RNA-binding protein YBX3 promotes PPARγ-SLC3A2 mediated BCAA metabolism fueling brown adipogenesis and thermogenesis","authors":"Lin-Yun Chen ,&nbsp;Li-Wen Wang ,&nbsp;Jie Wen ,&nbsp;Jing-Dong Cao ,&nbsp;Rui Zhou ,&nbsp;Jin-Lin Yang ,&nbsp;Ye Xiao ,&nbsp;Tian Su ,&nbsp;Yan Huang ,&nbsp;Qi Guo ,&nbsp;Hai-Yan Zhou ,&nbsp;Xiang-Hang Luo ,&nbsp;Xu Feng","doi":"10.1016/j.molmet.2024.102053","DOIUrl":"10.1016/j.molmet.2024.102053","url":null,"abstract":"<div><h3>Objective</h3><div>Activating brown adipose tissue (BAT) thermogenesis is a promising approach to combat obesity and metabolic disorders. The post-transcriptional regulation of BAT thermogenesis mediated by RNA-binding proteins (RBPs) is still not fully understood. This study explores the physiological role of novel RBPs in BAT differentiation and thermogenesis.</div></div><div><h3>Methods</h3><div>We used multiple public datasets to screen out novel RBPs responsible for BAT differentiation and thermogenesis. In vitro loss- and gain-of-function experiments were performed in both C3H10T1/2 preadipocytes and mature brown adipocytes to determine the role of Y-box binding protein 3 (YBX3) in brown adipocyte differentiation and thermogenesis. Adeno-associated virus (AAV)-mediated BAT-specific knockdown or overexpression of <em>Ybx3</em> was applied to investigate the function of YBX3 <em>in vivo</em>.</div></div><div><h3>Results</h3><div>YBX3 is a brown adipocyte-enriched RBP induced by cold stimulation and β-adrenergic signaling. Both <em>in vitro</em> loss- and gain-of-function experiments demonstrate that YBX3 is essential for brown adipocyte differentiation and thermogenesis. BAT-specific loss of <em>Ybx3</em> dampens thermogenesis and exacerbates diet-induced obesity in mice, while overexpression of <em>Ybx3</em> promotes thermogenesis and confers protection against diet-induced metabolic dysfunction. Transcriptome analysis and mitochondrial stress test indicate that <em>Ybx3</em> deficiency compromises the mitochondrial oxidative phosphorylation, leading to thermogenic failure. Mechanistically, YBX3 stabilizes the mRNA of <em>Slc3a2</em> and <em>Pparg</em>, which facilitates branched-chain amino acid (BCAA) influx and catabolism and fuels brown adipocyte differentiation and thermogenesis.</div></div><div><h3>Conclusions</h3><div>YBX3 facilitates BAT fueling BCAA to boost thermogenesis and energy expenditure, which protects against obesity and metabolic dysfunction. Thus, YBX3 could be a promising therapeutic target for obesity.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102053"},"PeriodicalIF":7.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Macrophages on the run: Exercise balances macrophage polarization for improved health 奔跑中的巨噬细胞:运动平衡巨噬细胞极化,改善健康状况。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-29 DOI: 10.1016/j.molmet.2024.102058
Yotam Voskoboynik , Andrew D. McCulloch , Debashis Sahoo

Objective

Exercise plays a crucial role in maintaining and improving human health. However, the precise molecular mechanisms that govern the body’s response to exercise or/compared to periods of inactivity remain elusive. Current evidence appears to suggest that exercise exerts a seemingly dual influence on macrophage polarization states, inducing both pro-immune response M1 activation and cell-repair-focused M2 activation. To reconcile this apparent paradox, we leveraged a comprehensive meta-analysis of 75 diverse exercise and immobilization published datasets (7000+ samples), encompassing various exercise modalities, sampling techniques, and species.

Methods

75 exercise and immobilization expression datasets were identified and processed for analysis. The data was analyzed using boolean relationships which uses binary gene expression relationships in order to increase the signal to noise achieved from the data, allowing for the use of comparison across such a diverse set of datasets. We utilized a boolean relationship-aided macrophage gene model [1], to model the macrophage polarization state in pre and post exercise samples in both immediate exercise and long term training.

Results

Our modeling uncovered a key temporal dynamic: exercise triggers an immediate M1 surge, while long term training transitions to sustained M2 activation. These patterns were consistent across different species (human vs mouse), sampling methods (blood vs muscle biopsy), and exercise type (resistance vs endurance), and routinely showed statistically significant results. Immobilization was shown to have the opposite effect of exercise by triggering an immediate M2 activation. Individual characteristics like gender, exercise intensity and age were found to impact the degree of polarization without changing the overall patterns. To model macrophages within the specific context of muscle tissue, we identified a focused gene set signature of muscle resident macrophage polarization, allowing for the precise measurement of macrophage activity in response to exercise within the muscle.

Conclusions

These consistent patterns across all 75 examined studies suggest that the long term health benefits of exercise stem from its ability to orchestrate a balanced and temporally-regulated interplay between pro-immune response (M1) and reparative macrophage activity (M2). Similarly, it suggests that an imbalance between pro-immune and cell repair responses could facilitate disease development. Our findings shed light on the intricate molecular choreography behind exercise-induced health benefits with a particular insight on its effect on the macrophages within the muscle.
目的:运动在保持和改善人体健康方面发挥着至关重要的作用。然而,机体对运动或/与非运动时期相比的反应的确切分子机制仍然难以捉摸。目前的证据似乎表明,运动对巨噬细胞极化状态似乎具有双重影响,既能诱导促免疫反应的 M1 激活,又能诱导注重细胞修复的 M2 激活。为了调和这一明显的悖论,我们对已发表的 75 个不同的运动和固定数据集(7000 多个样本)进行了全面的荟萃分析,这些数据集涵盖了各种运动方式、取样技术和物种。使用布尔关系对数据进行分析,布尔关系使用二进制基因表达关系,以提高数据的信噪比,从而在如此多样的数据集之间进行比较。我们利用布尔关系辅助的巨噬细胞基因模型[1],对运动前和运动后样本中的巨噬细胞极化状态进行建模,包括即时运动和长期训练:结果:我们的模型发现了一个关键的时间动态:运动会立即引发 M1 激增,而长期训练则会过渡到持续的 M2 激活。这些模式在不同的物种(人类与小鼠)、采样方法(血液与肌肉活检)和运动类型(阻力与耐力)中都是一致的,并经常显示出具有统计学意义的结果。研究表明,静止不动与运动的效果相反,会立即引发 M2 激活。研究发现,性别、运动强度和年龄等个体特征会影响极化程度,但不会改变整体模式。为了在肌肉组织的特定环境中建立巨噬细胞模型,我们确定了肌肉常驻巨噬细胞极化的重点基因组特征,从而可以精确测量巨噬细胞对肌肉内运动的反应:结论:所有 75 项研究中的这些一致模式表明,运动对健康的长期益处源于其在促进免疫反应(M1)和修复性巨噬细胞活动(M2)之间协调平衡和时间调节相互作用的能力。同样,这也表明促免疫反应和细胞修复反应之间的失衡可能会促进疾病的发展。我们的研究结果揭示了运动对健康的益处背后错综复杂的分子机制,尤其是运动对肌肉中巨噬细胞的影响。
{"title":"Macrophages on the run: Exercise balances macrophage polarization for improved health","authors":"Yotam Voskoboynik ,&nbsp;Andrew D. McCulloch ,&nbsp;Debashis Sahoo","doi":"10.1016/j.molmet.2024.102058","DOIUrl":"10.1016/j.molmet.2024.102058","url":null,"abstract":"<div><h3>Objective</h3><div>Exercise plays a crucial role in maintaining and improving human health. However, the precise molecular mechanisms that govern the body’s response to exercise or/compared to periods of inactivity remain elusive. Current evidence appears to suggest that exercise exerts a seemingly dual influence on macrophage polarization states, inducing both pro-immune response M1 activation and cell-repair-focused M2 activation. To reconcile this apparent paradox, we leveraged a comprehensive meta-analysis of 75 diverse exercise and immobilization published datasets (7000+ samples), encompassing various exercise modalities, sampling techniques, and species.</div></div><div><h3>Methods</h3><div>75 exercise and immobilization expression datasets were identified and processed for analysis. The data was analyzed using boolean relationships which uses binary gene expression relationships in order to increase the signal to noise achieved from the data, allowing for the use of comparison across such a diverse set of datasets. We utilized a boolean relationship-aided macrophage gene model [1], to model the macrophage polarization state in pre and post exercise samples in both immediate exercise and long term training.</div></div><div><h3>Results</h3><div>Our modeling uncovered a key temporal dynamic: exercise triggers an immediate M1 surge, while long term training transitions to sustained M2 activation. These patterns were consistent across different species (human vs mouse), sampling methods (blood vs muscle biopsy), and exercise type (resistance vs endurance), and routinely showed statistically significant results. Immobilization was shown to have the opposite effect of exercise by triggering an immediate M2 activation. Individual characteristics like gender, exercise intensity and age were found to impact the degree of polarization without changing the overall patterns. To model macrophages within the specific context of muscle tissue, we identified a focused gene set signature of muscle resident macrophage polarization, allowing for the precise measurement of macrophage activity in response to exercise within the muscle.</div></div><div><h3>Conclusions</h3><div>These consistent patterns across all 75 examined studies suggest that the long term health benefits of exercise stem from its ability to orchestrate a balanced and temporally-regulated interplay between pro-immune response (M1) and reparative macrophage activity (M2). Similarly, it suggests that an imbalance between pro-immune and cell repair responses could facilitate disease development. Our findings shed light on the intricate molecular choreography behind exercise-induced health benefits with a particular insight on its effect on the macrophages within the muscle.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102058"},"PeriodicalIF":7.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142546428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TGF-β antagonism synergizes with PPARγ agonism to reduce fibrosis and enhance beige adipogenesis TGF-β 拮抗作用与 PPARγ 激动作用协同作用,可减少纤维化并促进米色脂肪生成。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-24 DOI: 10.1016/j.molmet.2024.102054
Young Jae Bahn , Yanling Wang , Pradeep Dagur , Nicholas Scott , Cheryl Cero , Kelly T. Long , Nhuquynh Nguyen , Aaron M. Cypess , Sushil G. Rane

Objectives

Adipose tissue depots vary markedly in their ability to store and metabolize triglycerides, undergo beige adipogenesis and susceptibility to metabolic disease. The molecular mechanisms that underlie such heterogeneity are not entirely clear. Previously, we showed that TGF-β signaling suppresses beige adipogenesis via repressing the recruitment of dedicated beige progenitors. Here, we find that TGF-β signals dynamically regulate the balance between adipose tissue fibrosis and beige adipogenesis.

Methods

We investigated adipose tissue depot-specific differences in activation of TGF-β signaling in response to dietary challenge. RNA-seq and fluorescence activated cell sorting was performed to identify and characterize cells responding to changes in TGF-β signaling status. Mouse models, pharmacological strategies and human adipose tissue analyses were performed to further define the influence of TGF-β signaling on fibrosis and functional beige adipogenesis.

Results

Elevated basal and high-fat diet inducible activation of TGF-β/Smad3 signaling was observed in the visceral adipose tissue depot. Activation of TGF-β/Smad3 signaling was associated with increased adipose tissue fibrosis. RNA-seq combined with fluorescence-activated cell sorting of stromal vascular fraction of epididymal white adipose tissue depot resulted in identification of TGF-β/Smad3 regulated ITGA5+ fibrogenic progenitors. TGF-β/Smad3 signal inhibition, genetically or pharmacologically, reduced fibrosis and increased functional beige adipogenesis. TGF-β/Smad3 antagonized the beneficial effects of PPARγ whereas TGF-β receptor 1 inhibition synergized with actions of rosiglitazone, a PPARγ agonist, to dampen fibrosis and promote beige adipogenesis. Positive correlation between TGF-β activation and ITGA5 was observed in human adipose tissue, with visceral adipose tissue depots exhibiting higher fibrosis potential than subcutaneous or brown adipose tissue depots.

Conclusions

Basal and high-fat diet inducible activation of TGF-β underlies the heterogeneity of adipose tissue depots. TGF-β/Smad3 activation promotes adipose tissue fibrosis and suppresses beige progenitors. Together, these dual mechanisms preclude functional beige adipogenesis. Controlled inhibition of TβRI signaling and concomitant PPARγ stimulation can suppress adipose tissue fibrosis and promote beige adipogenesis to improve metabolism.
目的:脂肪组织库在储存和代谢甘油三酯的能力、米色脂肪生成以及对代谢性疾病的易感性方面存在明显差异。导致这种异质性的分子机制尚不完全清楚。此前,我们发现 TGF-β 信号通过抑制专用米色祖细胞的招募来抑制米色脂肪的生成。在此,我们发现 TGF-β 信号可动态调节脂肪组织纤维化和米色脂肪生成之间的平衡:方法:我们研究了TGF-β信号激活对饮食挑战反应的脂肪组织特异性差异。通过RNA-seq和荧光激活细胞分选技术,我们识别了响应TGF-β信号状态变化的细胞并确定了其特征。通过小鼠模型、药理策略和人体脂肪组织分析,进一步确定了TGF-β信号转导对纤维化和功能性米色脂肪生成的影响:结果:在内脏脂肪组织库中观察到TGF-β/Smad3信号的基础激活和高脂饮食诱导激活升高。TGF-β/Smad3信号的激活与脂肪组织纤维化的增加有关。RNA-seq结合荧光激活细胞分选技术对附睾白色脂肪组织基质血管部分进行研究,结果发现了受TGF-β/Smad3调控的ITGA5+纤维化祖细胞。通过基因或药物抑制 TGF-β/Smad3 信号可减少纤维化并增加功能性米色脂肪生成。TGF-β/Smad3拮抗了PPARγ的有益作用,而TGF-β受体1抑制与PPARγ激动剂罗格列酮协同作用,抑制纤维化并促进米色脂肪生成。在人体脂肪组织中观察到了TGF-β激活与ITGA5之间的正相关性,内脏脂肪组织库比皮下或棕色脂肪组织库表现出更高的纤维化潜力:结论:基础和高脂饮食诱导的 TGF-β 激活是脂肪组织储层异质性的基础。TGF-β/Smad3活化可促进脂肪组织纤维化并抑制米色祖细胞。这些双重机制共同排除了功能性米色脂肪生成。有控制地抑制 TβR1 信号传导并同时刺激 PPARγ 可抑制脂肪组织纤维化并促进米色脂肪生成,从而改善新陈代谢。
{"title":"TGF-β antagonism synergizes with PPARγ agonism to reduce fibrosis and enhance beige adipogenesis","authors":"Young Jae Bahn ,&nbsp;Yanling Wang ,&nbsp;Pradeep Dagur ,&nbsp;Nicholas Scott ,&nbsp;Cheryl Cero ,&nbsp;Kelly T. Long ,&nbsp;Nhuquynh Nguyen ,&nbsp;Aaron M. Cypess ,&nbsp;Sushil G. Rane","doi":"10.1016/j.molmet.2024.102054","DOIUrl":"10.1016/j.molmet.2024.102054","url":null,"abstract":"<div><h3>Objectives</h3><div>Adipose tissue depots vary markedly in their ability to store and metabolize triglycerides, undergo beige adipogenesis and susceptibility to metabolic disease. The molecular mechanisms that underlie such heterogeneity are not entirely clear. Previously, we showed that TGF-β signaling suppresses beige adipogenesis via repressing the recruitment of dedicated beige progenitors. Here, we find that TGF-β signals dynamically regulate the balance between adipose tissue fibrosis and beige adipogenesis.</div></div><div><h3>Methods</h3><div>We investigated adipose tissue depot-specific differences in activation of TGF-β signaling in response to dietary challenge. RNA-seq and fluorescence activated cell sorting was performed to identify and characterize cells responding to changes in TGF-β signaling status. Mouse models, pharmacological strategies and human adipose tissue analyses were performed to further define the influence of TGF-β signaling on fibrosis and functional beige adipogenesis.</div></div><div><h3>Results</h3><div>Elevated basal and high-fat diet inducible activation of TGF-β/Smad3 signaling was observed in the visceral adipose tissue depot. Activation of TGF-β/Smad3 signaling was associated with increased adipose tissue fibrosis. RNA-seq combined with fluorescence-activated cell sorting of stromal vascular fraction of epididymal white adipose tissue depot resulted in identification of TGF-β/Smad3 regulated ITGA5+ fibrogenic progenitors. TGF-β/Smad3 signal inhibition, genetically or pharmacologically, reduced fibrosis and increased functional beige adipogenesis. TGF-β/Smad3 antagonized the beneficial effects of PPARγ whereas TGF-β receptor 1 inhibition synergized with actions of rosiglitazone, a PPARγ agonist, to dampen fibrosis and promote beige adipogenesis. Positive correlation between TGF-β activation and ITGA5 was observed in human adipose tissue, with visceral adipose tissue depots exhibiting higher fibrosis potential than subcutaneous or brown adipose tissue depots.</div></div><div><h3>Conclusions</h3><div>Basal and high-fat diet inducible activation of TGF-β underlies the heterogeneity of adipose tissue depots. TGF-β/Smad3 activation promotes adipose tissue fibrosis and suppresses beige progenitors. Together, these dual mechanisms preclude functional beige adipogenesis. Controlled inhibition of TβRI signaling and concomitant PPARγ stimulation can suppress adipose tissue fibrosis and promote beige adipogenesis to improve metabolism.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102054"},"PeriodicalIF":7.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PET imaging of sodium-glucose cotransporters (SGLTs): Unveiling metabolic dynamics in diabetes and oncology 钠-葡萄糖共转运体(SGLTs)的 PET 成像:揭示糖尿病和肿瘤的代谢动力学。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-23 DOI: 10.1016/j.molmet.2024.102055
Konrad Klimek , Xinyu Chen , Takanori Sasaki , Daniel Groener , Rudolf A. Werner , Takahiro Higuchi

Background

Sodium-glucose cotransporters (SGLTs) play a crucial role in glucose regulation and are essential therapeutic targets for diabetes management. Recent advancements have leveraged SGLT-targeted PET imaging to examine these transporters' roles in both health and disease.

Scope of Review

This review highlights recent innovations in PET imaging targeting SGLTs, with a particular focus on SGLT-specific radiotracers, such as alpha-methyl-4-deoxy-4-18F-fluoro-d-glucopyranoside (Me-4FDG). It emphasizes the advantages of these radiotracers over conventional 18F-2-fluoro-2-deoxy-d-glucose (2-FDG) imaging, especially in assessing SGLT activity. Additionally, the review addresses their potential in evaluating the pharmacodynamics of SGLT inhibitors, investigating metabolic changes in diabetes, and staging cancers.

Major Conclusions

SGLT-targeted PET imaging offers promising improvements in diagnostic accuracy and therapeutic planning. The findings underscore the physiological and pathological significance of SGLTs, indicating that this imaging approach could shape future diagnostic and therapeutic strategies in metabolic and oncologic fields.
利用钠-葡萄糖共转运体(SGLT)底物进行正电子发射断层扫描(PET)成像的出现,为了解各种疾病状态下的代谢改变开辟了一个新领域。SGLT 同工酶,特别是 SGLT2,在葡萄糖调节中起着关键作用,一直是糖尿病治疗的靶点。SGLT特异性放射性同位素,如α-甲基-4-脱氧-4-18F-氟-D-吡喃葡萄糖苷(Me-4FDG),提供了超越传统18F-2-氟-2-脱氧-D-葡萄糖(2-FDG)成像的机会,允许对SGLT活性进行有针对性的评估。本综述总结了 SGLT PET 成像的最新进展,强调了其对评估 SGLT 抑制剂的药效学、探索糖尿病患者的新陈代谢以及各种癌症分期的影响。这些发现的临床意义表明,治疗方法和诊断准确性可能会发生转变,从而让人们全面了解 SGLT 的生理和病理相关性。
{"title":"PET imaging of sodium-glucose cotransporters (SGLTs): Unveiling metabolic dynamics in diabetes and oncology","authors":"Konrad Klimek ,&nbsp;Xinyu Chen ,&nbsp;Takanori Sasaki ,&nbsp;Daniel Groener ,&nbsp;Rudolf A. Werner ,&nbsp;Takahiro Higuchi","doi":"10.1016/j.molmet.2024.102055","DOIUrl":"10.1016/j.molmet.2024.102055","url":null,"abstract":"<div><h3>Background</h3><div>Sodium-glucose cotransporters (SGLTs) play a crucial role in glucose regulation and are essential therapeutic targets for diabetes management. Recent advancements have leveraged SGLT-targeted PET imaging to examine these transporters' roles in both health and disease.</div></div><div><h3>Scope of Review</h3><div>This review highlights recent innovations in PET imaging targeting SGLTs, with a particular focus on SGLT-specific radiotracers, such as alpha-methyl-4-deoxy-4-<sup>18</sup>F-fluoro-<span>d</span>-glucopyranoside (Me-4FDG). It emphasizes the advantages of these radiotracers over conventional <sup>18</sup>F-2-fluoro-2-deoxy-<span>d</span>-glucose (2-FDG) imaging, especially in assessing SGLT activity. Additionally, the review addresses their potential in evaluating the pharmacodynamics of SGLT inhibitors, investigating metabolic changes in diabetes, and staging cancers.</div></div><div><h3>Major Conclusions</h3><div>SGLT-targeted PET imaging offers promising improvements in diagnostic accuracy and therapeutic planning. The findings underscore the physiological and pathological significance of SGLTs, indicating that this imaging approach could shape future diagnostic and therapeutic strategies in metabolic and oncologic fields.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102055"},"PeriodicalIF":7.0,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
cAMP driven UCP1 induction in human adipocytes requires ATGL-catalyzed lipolysis 人脂肪细胞中 cAMP 驱动的 UCP1 诱导需要 ATGL 催化脂肪分解。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-23 DOI: 10.1016/j.molmet.2024.102051
Anand Desai , Zinger Yang Loureiro , Tiffany DeSouza , Qin Yang , Javier Solivan-Rivera , Silvia Corvera

Objective

The uncoupling protein 1 (UCP1) is induced in brown or “beige” adipocytes through catecholamine-induced cAMP signaling, which activates diverse transcription factors. UCP1 expression can also be enhanced by PPARγ agonists such as rosiglitazone (Rsg). However, it is unclear whether this upregulation results from de-novo differentiation of beige adipocytes from progenitor cells, or from the induction of UCP1 in pre-existing adipocytes. To explore this, we employed human adipocytes differentiated from progenitor cells and examined their acute response to Rsg, to the adenylate-cyclase activator forskolin (Fsk), or to both simultaneously.

Methods

Adipocytes generated from primary human progenitor cells were differentiated without exposure to PPARγ agonists, and treated for 3, 6 or 78 h to Fsk, to Rsg, or to both simultaneously. Bulk RNASeq, RNAScope, RT-PCR, CRISPR-Cas9 mediated knockout, oxygen consumption and western blotting were used to assess cellular responses.

Results

UCP1 mRNA expression was induced within 3 h of exposure to either Rsg or Fsk, indicating that Rsg’s effect is independent on additional adipocyte differentiation. Although Rsg and Fsk induced distinct overall transcriptional responses, both induced genes associated with calcium metabolism, lipid droplet assembly, and mitochondrial remodeling, denoting core features of human adipocyte beiging. Unexpectedly, we found that Fsk-induced UCP1 expression was reduced by approximately 80% following CRISPR-Cas9-mediated knockout of PNPLA2, the gene encoding the triglyceride lipase ATGL. As anticipated, ATGL knockout suppressed lipolysis; however, the associated suppression of UCP1 induction indicates that maximal cAMP-mediated UCP1 induction requires products of ATGL-catalyzed lipolysis. Supporting this, we observed that the reduction in Fsk-stimulated UCP1 induction caused by ATGL knockout was reversed by Rsg, implying that the role of lipolysis in this process is to generate natural PPARγ agonists.

Conclusions

UCP1 transcription is known to be stimulated by transcription factors activated downstream of cAMP-dependent protein kinases. Here we demonstrate that UCP1 transcription can also be acutely induced through PPARγ-activation. Moreover, both pathways are activated in human adipocytes in response to cAMP, synergistically inducing UCP1 expression. The stimulation of PPARγ in response to cAMP may result from the production of natural PPARγ activating ligands through ATGL-mediated lipolysis.
目的:解偶联蛋白 1(UCP1)通过儿茶酚胺诱导的 cAMP 信号在棕色或 "米色 "脂肪细胞中被诱导,从而激活多种转录因子。PPARγ 激动剂如罗格列酮(Rsg)也能增强 UCP1 的表达。然而,目前还不清楚这种上调是源于米色脂肪细胞从祖细胞中重新分化,还是源于已存在的脂肪细胞对 UCP1 的诱导。为了探讨这个问题,我们使用了从祖细胞分化而来的人类脂肪细胞,并研究了它们对 Rsg、腺苷酸环化酶激活剂福斯可林(Fsk)或同时对这两种物质的急性反应:方法:在不接触 PPARγ 激动剂的情况下,对原代人类祖细胞产生的脂肪细胞进行分化,并对 Fsk、Rsg 或两者同时处理 3、6 或 78 小时。采用大量 RNASeq、RNAScope、RT-PCR、CRISPR-Cas9 介导的基因敲除、耗氧量和 Western 印迹法评估细胞反应:结果:UCP1 mRNA的表达在暴露于Rsg或Fsk后3小时内被诱导,这表明Rsg的作用与额外的脂肪细胞分化无关。尽管Rsg和Fsk诱导的整体转录反应不同,但两者都诱导了与钙代谢、脂滴组装和线粒体重塑相关的基因,这表明了人类脂肪细胞分化的核心特征。意想不到的是,我们发现在 CRISPR-Cas9 介导的 PNPLA2(编码甘油三酯脂肪酶 ATGL 的基因)敲除后,Fsk 诱导的 UCP1 表达减少了约 80%。正如预期的那样,ATGL基因敲除抑制了脂肪分解;然而,UCP1诱导的相关抑制表明,cAMP介导的最大UCP1诱导需要ATGL催化脂肪分解的产物。与此相佐证的是,我们观察到 ATGL 基因敲除导致的 Fsk 刺激 UCP1 诱导的减少被 Rsg 逆转,这意味着脂肪分解在此过程中的作用是产生天然 PPARγ 激动剂:结论:众所周知,UCP1 的转录是由 cAMP 依赖性蛋白激酶下游激活的转录因子刺激的。我们在此证明,UCP1 的转录也可通过 PPARγ 激活而被急性诱导。此外,在人类脂肪细胞中,这两种途径都会在 cAMP 作用下被激活,从而协同诱导 UCP1 的表达。cAMP 对 PPARγ 的刺激可能是通过 ATGL 介导的脂肪分解产生天然 PPARγ 激活配体的结果。
{"title":"cAMP driven UCP1 induction in human adipocytes requires ATGL-catalyzed lipolysis","authors":"Anand Desai ,&nbsp;Zinger Yang Loureiro ,&nbsp;Tiffany DeSouza ,&nbsp;Qin Yang ,&nbsp;Javier Solivan-Rivera ,&nbsp;Silvia Corvera","doi":"10.1016/j.molmet.2024.102051","DOIUrl":"10.1016/j.molmet.2024.102051","url":null,"abstract":"<div><h3>Objective</h3><div>The uncoupling protein 1 (UCP1) is induced in brown or “beige” adipocytes through catecholamine-induced cAMP signaling, which activates diverse transcription factors. UCP1 expression can also be enhanced by PPARγ agonists such as rosiglitazone (Rsg). However, it is unclear whether this upregulation results from de-novo differentiation of beige adipocytes from progenitor cells, or from the induction of UCP1 in pre-existing adipocytes. To explore this, we employed human adipocytes differentiated from progenitor cells and examined their acute response to Rsg, to the adenylate-cyclase activator forskolin (Fsk), or to both simultaneously.</div></div><div><h3>Methods</h3><div>Adipocytes generated from primary human progenitor cells were differentiated without exposure to PPARγ agonists, and treated for 3, 6 or 78 h to Fsk, to Rsg, or to both simultaneously. Bulk RNASeq, RNAScope, RT-PCR, CRISPR-Cas9 mediated knockout, oxygen consumption and western blotting were used to assess cellular responses.</div></div><div><h3>Results</h3><div><em>UCP1</em> mRNA expression was induced within 3 h of exposure to either Rsg or Fsk, indicating that Rsg’s effect is independent on additional adipocyte differentiation. Although Rsg and Fsk induced distinct overall transcriptional responses, both induced genes associated with calcium metabolism, lipid droplet assembly, and mitochondrial remodeling, denoting core features of human adipocyte beiging. Unexpectedly, we found that Fsk-induced <em>UCP1</em> expression was reduced by approximately 80% following CRISPR-Cas9-mediated knockout of <em>PNPLA2</em>, the gene encoding the triglyceride lipase ATGL. As anticipated, ATGL knockout suppressed lipolysis; however, the associated suppression of UCP1 induction indicates that maximal cAMP-mediated <em>UCP1</em> induction requires products of ATGL-catalyzed lipolysis. Supporting this, we observed that the reduction in Fsk-stimulated UCP1 induction caused by ATGL knockout was reversed by Rsg, implying that the role of lipolysis in this process is to generate natural PPARγ agonists.</div></div><div><h3>Conclusions</h3><div><em>UCP1</em> transcription is known to be stimulated by transcription factors activated downstream of cAMP-dependent protein kinases. Here we demonstrate that <em>UCP1</em> transcription can also be acutely induced through PPARγ-activation. Moreover, both pathways are activated in human adipocytes in response to cAMP, synergistically inducing UCP1 expression. The stimulation of PPARγ in response to cAMP may result from the production of natural PPARγ activating ligands through ATGL-mediated lipolysis.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102051"},"PeriodicalIF":7.0,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interruption of glucagon signaling augments islet non-alpha cell proliferation in SLC7A2- and mTOR-dependent manners 胰高血糖素信号的中断会以 SLC7A2- 和 mTOR 依赖性方式促进胰岛非α细胞的增殖。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-20 DOI: 10.1016/j.molmet.2024.102050
Katie C. Coate , Chunhua Dai , Ajay Singh , Jade Stanley , Brittney A. Covington , Amber Bradley , Favour Oladipupo , Yulong Gong , Scott Wisniewski , Katelyn Sellick , Erick Spears , Greg Poffenberger , Anna Marie R. Schornack , Alexandria Bustabad , Tyler Rodgers , Nandita Dey , Leonard D. Shultz , Dale L. Greiner , Hai Yan , Alvin C. Powers , E. Danielle Dean

Objective

Dysregulated glucagon secretion and inadequate functional beta cell mass are hallmark features of diabetes. While glucagon receptor (GCGR) antagonism ameliorates hyperglycemia and elicits beta cell regeneration in pre-clinical models of diabetes, it also promotes alpha and delta cell hyperplasia. We sought to investigate the mechanism by which loss of glucagon action impacts pancreatic islet non-alpha cells, and the relevance of these observations in a human islet context.

Methods

We used zebrafish, rodents, and transplanted human islets comprising six different models of interrupted glucagon signaling to examine their impact on delta and beta cell proliferation and mass. We also used models with global deficiency of the cationic amino acid transporter, SLC7A2, and mTORC1 inhibition via rapamycin, to determine whether amino acid-dependent nutrient sensing was required for islet non-alpha cell growth.

Results

Inhibition of glucagon signaling stimulated delta cell proliferation in mouse and transplanted human islets, and in mouse islets. This was rapamycin-sensitive and required SLC7A2. Likewise, gcgr deficiency augmented beta cell proliferation via SLC7A2- and mTORC1-dependent mechanisms in zebrafish and promoted cell cycle engagement in rodent beta cells but was insufficient to drive a significant increase in beta cell mass in mice.

Conclusions

Our findings demonstrate that interruption of glucagon signaling augments islet non-alpha cell proliferation in zebrafish, rodents, and transplanted human islets in a manner requiring SLC7A2 and mTORC1 activation. An increase in delta cell mass may be leveraged for future beta cell regeneration therapies relying upon delta cell reprogramming.
目的:胰高血糖素分泌失调和功能性β细胞数量不足是糖尿病的标志性特征。在糖尿病临床前模型中,胰高血糖素受体(GCGR)拮抗能改善高血糖症状并促进β细胞再生,但同时也会促进α和δ细胞增生。我们试图研究胰高血糖素作用的丧失影响胰岛非α细胞的机制,以及这些观察结果与人类胰岛的相关性:我们使用斑马鱼、啮齿动物和移植的人类胰岛,包括六种不同的胰高血糖素信号中断模型,研究它们对δ和β细胞增殖和质量的影响。我们还利用阳离子氨基酸转运体 SLC7A2 的全面缺乏和通过雷帕霉素抑制 mTORC1 的模型,来确定胰岛非α细胞的生长是否需要依赖氨基酸的营养传感:结果:抑制胰高血糖素信号传导可刺激小鼠和移植人胰岛以及小鼠胰岛中的δ细胞增殖。这对雷帕霉素敏感,并且需要 SLC7A2。同样,在斑马鱼体内,gcgr 缺乏通过 SLC7A2- 和 mTORC1 依赖性机制增强了β细胞增殖,并促进了啮齿动物β细胞的细胞周期参与,但不足以驱动小鼠β细胞质量的显著增加:我们的研究结果表明,在斑马鱼、啮齿动物和移植的人类胰岛中,胰高血糖素信号的中断会以一种需要 SLC7A2 和 mTORC1 激活的方式促进胰岛非α细胞的增殖。δ细胞质量的增加可用于未来依赖δ细胞重编程的β细胞再生疗法。
{"title":"Interruption of glucagon signaling augments islet non-alpha cell proliferation in SLC7A2- and mTOR-dependent manners","authors":"Katie C. Coate ,&nbsp;Chunhua Dai ,&nbsp;Ajay Singh ,&nbsp;Jade Stanley ,&nbsp;Brittney A. Covington ,&nbsp;Amber Bradley ,&nbsp;Favour Oladipupo ,&nbsp;Yulong Gong ,&nbsp;Scott Wisniewski ,&nbsp;Katelyn Sellick ,&nbsp;Erick Spears ,&nbsp;Greg Poffenberger ,&nbsp;Anna Marie R. Schornack ,&nbsp;Alexandria Bustabad ,&nbsp;Tyler Rodgers ,&nbsp;Nandita Dey ,&nbsp;Leonard D. Shultz ,&nbsp;Dale L. Greiner ,&nbsp;Hai Yan ,&nbsp;Alvin C. Powers ,&nbsp;E. Danielle Dean","doi":"10.1016/j.molmet.2024.102050","DOIUrl":"10.1016/j.molmet.2024.102050","url":null,"abstract":"<div><h3>Objective</h3><div>Dysregulated glucagon secretion and inadequate functional beta cell mass are hallmark features of diabetes. While glucagon receptor (GCGR) antagonism ameliorates hyperglycemia and elicits beta cell regeneration in pre-clinical models of diabetes, it also promotes alpha and delta cell hyperplasia. We sought to investigate the mechanism by which loss of glucagon action impacts pancreatic islet non-alpha cells, and the relevance of these observations in a human islet context.</div></div><div><h3>Methods</h3><div>We used zebrafish, rodents, and transplanted human islets comprising six different models of interrupted glucagon signaling to examine their impact on delta and beta cell proliferation and mass. We also used models with global deficiency of the cationic amino acid transporter, SLC7A2, and mTORC1 inhibition via rapamycin, to determine whether amino acid-dependent nutrient sensing was required for islet non-alpha cell growth.</div></div><div><h3>Results</h3><div>Inhibition of glucagon signaling stimulated delta cell proliferation in mouse and transplanted human islets, and in mouse islets. This was rapamycin-sensitive and required SLC7A2. Likewise, <em>gcgr</em> deficiency augmented beta cell proliferation via SLC7A2- and mTORC1-dependent mechanisms in zebrafish and promoted cell cycle engagement in rodent beta cells but was insufficient to drive a significant increase in beta cell mass in mice.</div></div><div><h3>Conclusions</h3><div>Our findings demonstrate that interruption of glucagon signaling augments islet non-alpha cell proliferation in zebrafish, rodents, and transplanted human islets in a manner requiring SLC7A2 and mTORC1 activation. An increase in delta cell mass may be leveraged for future beta cell regeneration therapies relying upon delta cell reprogramming.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102050"},"PeriodicalIF":7.0,"publicationDate":"2024-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142470188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FITM2 deficiency results in ER lipid accumulation, ER stress, and reduced apolipoprotein B lipidation and VLDL triglyceride secretion in vitro and in mouse liver FITM2 缺乏会导致体外和小鼠肝脏中的ER脂质积累、ER应激、载脂蛋白B脂化和VLDL甘油三酯分泌减少。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-18 DOI: 10.1016/j.molmet.2024.102048
Haizhen Wang , Cyrus Nikain , Konstantinos I. Fortounas , Jaume Amengual , Ozlem Tufanli , Maxwell La Forest , Yong Yu , Meng C. Wang , Russell Watts , Richard Lehner , Yunping Qiu , Min Cai , Irwin J. Kurland , Ira J. Goldberg , Sujith Rajan , M. Mahmood Hussain , Jeffrey L. Brodsky , Edward A. Fisher

Objective

Triglycerides (TGs) associate with apolipoprotein B100 (apoB100) to form very low density lipoproteins (VLDLs) in the liver. The repertoire of factors that facilitate this association is incompletely understood. FITM2, an integral endoplasmic reticulum (ER) protein, was originally discovered as a factor participating in cytosolic lipid droplet (LD) biogenesis in tissues that do not form VLDL. We hypothesized that in the liver, in addition to promoting cytosolic LD formation, FITM2 would also transfer TG from its site of synthesis in the ER membrane to nascent VLDL particles within the ER lumen.

Methods

Experiments were conducted using a rat hepatic cell line (McArdle-RH7777, or McA cells), an established model of mammalian lipoprotein metabolism, and mice. FITM2 expression was reduced using siRNA in cells and by liver specific cre-recombinase mediated deletion of the Fitm2 gene in mice. Effects of FITM2 deficiency on VLDL assembly and secretion in vitro and in vivo were measured by multiple methods, including density gradient ultracentrifugation, chromatography, mass spectrometry, stimulated Raman scattering (SRS) microscopy, sub-cellular fractionation, immunoprecipitation, immunofluorescence, and electron microscopy.

Main findings

1) FITM2-deficient hepatic cells in vitro and in vivo secrete TG-depleted VLDL particles, but the number of particles is unchanged compared to controls; 2) FITM2 deficiency in mice on a high fat diet (HFD) results in decreased plasma TG levels. The number of apoB100-containing lipoproteins remains similar, but shift from VLDL to low density lipoprotein (LDL) density; 3) Both in vitro and in vivo, when TG synthesis is stimulated and FITM2 is deficient, TG accumulates in the ER, and despite its availability this pool is unable to fully lipidate apoB100 particles; 4) FITM2 deficiency disrupts ER morphology and results in ER stress.

Conclusion

The results suggest that FITM2 contributes to VLDL lipidation, especially when newly synthesized hepatic TG is in abundance. In addition to its fundamental importance in VLDL assembly, the results also suggest that under dysmetabolic conditions, FITM2 may be an important factor in the partitioning of TG between cytosolic LDs and VLDL particles.
目的:甘油三酯(TGs)与载脂蛋白 B100(apoB100)结合,在肝脏中形成极低密度脂蛋白(VLDLs)。目前还不完全清楚促进这种结合的一系列因素。FITM2是一种完整的内质网(ER)蛋白,最初是作为一种参与细胞膜脂滴(LD)生物生成的因子在不形成VLDL的组织中被发现的。我们假设,在肝脏中,FITM2 除了促进细胞膜脂滴的形成外,还能将 TG 从其在 ER 膜上的合成部位转移到 ER 腔内的新生 VLDL 颗粒中:实验使用大鼠肝细胞系(McArdle-RH7777,或 McA 细胞)(哺乳动物脂蛋白代谢的成熟模型)和小鼠进行。在细胞中使用 siRNA 减少 FITM2 的表达,在小鼠中使用肝脏特异性 cre-recombinase 介导的 Fitm2 基因缺失。通过多种方法,包括密度梯度超速离心、色谱法、质谱法、刺激拉曼散射(SRS)显微镜、亚细胞分馏、免疫沉淀、免疫荧光和电子显微镜,测定了 FITM2 缺乏对体外和体内 VLDL 组装和分泌的影响:主要发现:1)体外和体内 FITM2 缺乏的肝细胞分泌去TG的 VLDL 颗粒,但颗粒数量与对照组相比没有变化;2)高脂饮食(HFD)小鼠 FITM2 缺乏导致血浆 TG 水平下降。含载脂蛋白 B100 的脂蛋白数量保持相似,但密度从 VLDL 转向低密度脂蛋白(LDL);3)在体外和体内,当 TG 合成受到刺激而 FITM2 缺乏时,TG 在 ER 中积累,尽管可以获得 TG,但该库无法完全脂化载脂蛋白 B100 颗粒;4)FITM2 缺乏会破坏 ER 形态并导致 ER 应激:研究结果表明,FITM2 有助于 VLDL 脂化,尤其是在新合成的肝脏 TG 大量存在时。除了在 VLDL 组装过程中发挥重要作用外,研究结果还表明,在代谢紊乱条件下,FITM2 可能是在细胞膜低密度脂蛋白和 VLDL 颗粒之间分配 TG 的一个重要因素。
{"title":"FITM2 deficiency results in ER lipid accumulation, ER stress, and reduced apolipoprotein B lipidation and VLDL triglyceride secretion in vitro and in mouse liver","authors":"Haizhen Wang ,&nbsp;Cyrus Nikain ,&nbsp;Konstantinos I. Fortounas ,&nbsp;Jaume Amengual ,&nbsp;Ozlem Tufanli ,&nbsp;Maxwell La Forest ,&nbsp;Yong Yu ,&nbsp;Meng C. Wang ,&nbsp;Russell Watts ,&nbsp;Richard Lehner ,&nbsp;Yunping Qiu ,&nbsp;Min Cai ,&nbsp;Irwin J. Kurland ,&nbsp;Ira J. Goldberg ,&nbsp;Sujith Rajan ,&nbsp;M. Mahmood Hussain ,&nbsp;Jeffrey L. Brodsky ,&nbsp;Edward A. Fisher","doi":"10.1016/j.molmet.2024.102048","DOIUrl":"10.1016/j.molmet.2024.102048","url":null,"abstract":"<div><h3>Objective</h3><div>Triglycerides (TGs) associate with apolipoprotein B100 (apoB100) to form very low density lipoproteins (VLDLs) in the liver. The repertoire of factors that facilitate this association is incompletely understood. FITM2, an integral endoplasmic reticulum (ER) protein, was originally discovered as a factor participating in cytosolic lipid droplet (LD) biogenesis in tissues that do not form VLDL. We hypothesized that in the liver, in addition to promoting cytosolic LD formation, FITM2 would also transfer TG from its site of synthesis in the ER membrane to nascent VLDL particles within the ER lumen.</div></div><div><h3>Methods</h3><div>Experiments were conducted using a rat hepatic cell line (McArdle-RH7777, or McA cells), an established model of mammalian lipoprotein metabolism, and mice. FITM2 expression was reduced using siRNA in cells and by liver specific cre-recombinase mediated deletion of the <em>Fitm2</em> gene in mice. Effects of FITM2 deficiency on VLDL assembly and secretion <em>in vitro</em> and <em>in vivo</em> were measured by multiple methods, including density gradient ultracentrifugation, chromatography, mass spectrometry, stimulated Raman scattering (SRS) microscopy, sub-cellular fractionation, immunoprecipitation, immunofluorescence, and electron microscopy.</div></div><div><h3>Main findings</h3><div>1) FITM2-deficient hepatic cells <em>in vitro</em> and <em>in vivo</em> secrete TG-depleted VLDL particles, but the number of particles is unchanged compared to controls; 2) FITM2 deficiency in mice on a high fat diet (HFD) results in decreased plasma TG levels. The number of apoB100-containing lipoproteins remains similar, but shift from VLDL to low density lipoprotein (LDL) density; 3) Both <em>in vitro</em> and <em>in vivo</em>, when TG synthesis is stimulated and FITM2 is deficient, TG accumulates in the ER, and despite its availability this pool is unable to fully lipidate apoB100 particles; 4) FITM2 deficiency disrupts ER morphology and results in ER stress.</div></div><div><h3>Conclusion</h3><div>The results suggest that FITM2 contributes to VLDL lipidation, especially when newly synthesized hepatic TG is in abundance. In addition to its fundamental importance in VLDL assembly, the results also suggest that under dysmetabolic conditions, FITM2 may be an important factor in the partitioning of TG between cytosolic LDs and VLDL particles.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102048"},"PeriodicalIF":7.0,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142470174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distinct genetic signals at the FGF21 locus complicate studies of FGF21's role in diet regulation using human cohort data FGF21 基因座上不同的遗传信号使利用人类队列数据研究 FGF21 在饮食调节中的作用变得更加复杂。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-18 DOI: 10.1016/j.molmet.2024.102049
Stina Ramne , Mario García-Ureña , Matthew P. Gillum , Lars Ängquist , Torben Hansen , Jordi Merino , Niels Grarup

Objectives

Experimental and genetic studies suggest that fibroblast growth factor 21 (FGF21) modulates macronutrient and alcohol preferences, but evidence of such regulation in humans remains scarce. To address this gap in translation, we aimed to map the relationships between plasma FGF21 levels, FGF21 genetic variation and habitual macronutrient intake in a large human population.

Methods

We fine-mapped and performed colocalization of the FGF21 genetic region in GWAS summary statistics of plasma FGF21 levels and macronutrient intake. UK Biobank data were used to investigate the associations between FGF21 genetic variants, plasma FGF21 protein levels, and macronutrient intake (including alcohol) assessed with repeated 24-hour recalls. One- and two-sample mendelian randomization were performed to estimate the effects of plasma FGF21 on macronutrient intake.

Results

We show that the main macronutrient-associated variant rs838133 and the FGF21 cis-pQTL rs838131, both in the FGF21 gene, are distinct genetic signals. Effect directions also suggest that the influence of FGF21 variation on macronutrient intake appear more complex than by direct mediation through plasma FGF21. Only when considering this complexity at FGF21, is plasma FGF21 estimated to reduce alcohol and increase protein and fat intake using mendelian randomization. Importantly, plasma FGF21 levels also appear markedly elevated by primarily high alcohol and low protein intake.

Conclusions

These findings support the feedback diet-regulatory mechanism of FGF21 in humans, but highlights the need for mechanistic characterization of the complex FGF21 genetic region.
目的:实验和遗传学研究表明,成纤维细胞生长因子21(FGF21)可调节对高营养素和酒精的偏好,但在人类中这种调节的证据仍然很少。为了填补这一空白,我们旨在绘制大量人类血浆 FGF21 水平、FGF21 遗传变异和习惯性高营养素摄入量之间的关系图:我们在血浆 FGF21 水平和宏量营养素摄入量的 GWAS 概要统计中对 FGF21 遗传区域进行了精细绘制和共定位。英国生物库数据被用来研究 FGF21 基因变异、血浆 FGF21 蛋白水平和 24 小时重复回忆评估的宏量营养素摄入量(包括酒精)之间的关联。为了估计血浆FGF21对宏量营养素摄入的影响,我们采用了单样本和双样本泯灭随机法:结果:我们发现,与宏量营养素相关的主要变异体 rs838133 和 FGF21 顺式-pQTL rs838131 都位于 FGF21 基因中,它们是不同的遗传信号。效应方向还表明,FGF21 变异对宏量营养素摄入的影响似乎比通过血浆 FGF21 直接介导的影响更为复杂。只有在考虑到 FGF21 的这种复杂性时,才会使用亡羊补牢随机法估计血浆 FGF21 会减少酒精摄入量,增加蛋白质和脂肪摄入量。重要的是,血浆 FGF21 水平也会因酒精摄入量高和蛋白质摄入量低而明显升高:这些发现支持人类 FGF21 的反馈性饮食调节机制,但强调了对复杂的 FGF21 遗传区域进行机制表征的必要性。
{"title":"Distinct genetic signals at the FGF21 locus complicate studies of FGF21's role in diet regulation using human cohort data","authors":"Stina Ramne ,&nbsp;Mario García-Ureña ,&nbsp;Matthew P. Gillum ,&nbsp;Lars Ängquist ,&nbsp;Torben Hansen ,&nbsp;Jordi Merino ,&nbsp;Niels Grarup","doi":"10.1016/j.molmet.2024.102049","DOIUrl":"10.1016/j.molmet.2024.102049","url":null,"abstract":"<div><h3>Objectives</h3><div>Experimental and genetic studies suggest that fibroblast growth factor 21 (FGF21) modulates macronutrient and alcohol preferences, but evidence of such regulation in humans remains scarce. To address this gap in translation, we aimed to map the relationships between plasma FGF21 levels, <em>FGF21</em> genetic variation and habitual macronutrient intake in a large human population.</div></div><div><h3>Methods</h3><div>We fine-mapped and performed colocalization of the <em>FGF21</em> genetic region in GWAS summary statistics of plasma FGF21 levels and macronutrient intake. UK Biobank data were used to investigate the associations between <em>FGF21</em> genetic variants, plasma FGF21 protein levels, and macronutrient intake (including alcohol) assessed with repeated 24-hour recalls. One- and two-sample mendelian randomization were performed to estimate the effects of plasma FGF21 on macronutrient intake.</div></div><div><h3>Results</h3><div>We show that the main macronutrient-associated variant rs838133 and the FGF21 cis-pQTL rs838131, both in the <em>FGF21</em> gene, are distinct genetic signals. Effect directions also suggest that the influence of <em>FGF21</em> variation on macronutrient intake appear more complex than by direct mediation through plasma FGF21. Only when considering this complexity at <em>FGF21,</em> is plasma FGF21 estimated to reduce alcohol and increase protein and fat intake using mendelian randomization. Importantly, plasma FGF21 levels also appear markedly elevated by primarily high alcohol and low protein intake.</div></div><div><h3>Conclusions</h3><div>These findings support the feedback diet-regulatory mechanism of FGF21 in humans, but highlights the need for mechanistic characterization of the complex <em>FGF21</em> genetic region.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102049"},"PeriodicalIF":7.0,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142470172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distinct roles for the domains of the mitochondrial aspartate/glutamate carrier citrin in organellar localization and substrate transport 线粒体天冬氨酸/谷氨酸载体柠檬蛋白的结构域在细胞器定位和底物运输中的不同作用
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-16 DOI: 10.1016/j.molmet.2024.102047
Sotiria Tavoulari , Denis Lacabanne , Gonçalo C. Pereira , Chancievan Thangaratnarajah, Martin S. King, Jiuya He, Suvagata R. Chowdhury, Lisa Tilokani, Shane M. Palmer, Julien Prudent, John E. Walker, Edmund R.S. Kunji

Objective

Citrin, the mitochondrial aspartate/glutamate carrier isoform 2 (AGC2), is structurally and mechanistically the most complex SLC25 family member, because it consists of three domains and forms a homo-dimer. Each protomer has an N-terminal calcium-binding domain with EF-hands, followed by a substrate-transporting carrier domain and a C-terminal domain with an amphipathic helix. The absence or dysfunction of citrin leads to citrin deficiency, a highly prevalent pan-ethnic mitochondrial disease. Here, we aim to understand the role of different citrin domains and how they contribute to pathogenic mechanisms in citrin deficiency.

Methods

We have employed structural modeling and functional reconstitution of purified proteins in proteoliposomes to assess the transport activity and calcium regulation of wild-type citrin and pathogenic variants associated with citrin deficiency. We have also developed a double knockout of citrin and aralar (AGC1), the two paralogs of the mitochondrial aspartate/glutamate carrier, in HAP1 cells to perform mitochondrial imaging and to investigate mitochondrial localisation.

Results

Using 33 pathogenic variants of citrin we clarify determinants of subcellular localization and transport mechanism. We identify crucial elements of the carrier domain that are required for transport, including those involved in substrate binding, network formation and dynamics. We show that the N-terminal domain is not involved in calcium regulation of transport, as previously thought, but when mutated causes a mitochondrial import defect.

Conclusions

Our work introduces a new role for the N-terminal domain of citrin and demonstrates that dysfunction of the different domains contributes to distinct pathogenic mechanisms in citrin deficiency.
目的:线粒体天冬氨酸/谷氨酸载体同工酶 2 是结构和机理上最复杂的 SLC25 家族成员,因为它由三个结构域组成,并形成一个同源二聚体。每个原体都有一个带有 EF 手的 N 端钙结合结构域、一个底物运输载体结构域和一个带有两性螺旋的 C 端结构域。柠檬蛋白的缺失或功能障碍导致柠檬蛋白缺乏症,这是一种高发的泛种族线粒体疾病。在此,我们旨在了解不同 citrin 结构域的作用,以及它们如何在 citrin 缺乏症的致病机制中发挥作用:方法:我们利用结构建模和蛋白脂质体中纯化蛋白的功能重组来评估野生型citrin和与citrin缺乏症相关的致病变体的转运活性和钙调控。我们还在HAP1细胞中开发了线粒体天冬氨酸/谷氨酸载体的两个旁系亲属--citrin和aralar(AGC1)的双基因敲除,以进行线粒体成像并研究线粒体定位:结果:我们利用柠檬蛋白的 33 个致病变体阐明了亚细胞定位和转运机制的决定因素。我们确定了运输所需的载体结构域的关键元素,包括参与底物结合、网络形成和动力学的元素。我们发现 N 端结构域并不像以前认为的那样参与运输的钙调控,而是在发生突变时导致线粒体输入缺陷:我们的研究为柠檬蛋白的 N 端结构域引入了一个新的角色,并证明不同结构域的功能障碍会导致柠檬蛋白缺乏症的不同致病机制。
{"title":"Distinct roles for the domains of the mitochondrial aspartate/glutamate carrier citrin in organellar localization and substrate transport","authors":"Sotiria Tavoulari ,&nbsp;Denis Lacabanne ,&nbsp;Gonçalo C. Pereira ,&nbsp;Chancievan Thangaratnarajah,&nbsp;Martin S. King,&nbsp;Jiuya He,&nbsp;Suvagata R. Chowdhury,&nbsp;Lisa Tilokani,&nbsp;Shane M. Palmer,&nbsp;Julien Prudent,&nbsp;John E. Walker,&nbsp;Edmund R.S. Kunji","doi":"10.1016/j.molmet.2024.102047","DOIUrl":"10.1016/j.molmet.2024.102047","url":null,"abstract":"<div><h3>Objective</h3><div>Citrin, the mitochondrial aspartate/glutamate carrier isoform 2 (AGC2), is structurally and mechanistically the most complex SLC25 family member, because it consists of three domains and forms a homo-dimer. Each protomer has an N-terminal calcium-binding domain with EF-hands, followed by a substrate-transporting carrier domain and a C-terminal domain with an amphipathic helix. The absence or dysfunction of citrin leads to citrin deficiency, a highly prevalent pan-ethnic mitochondrial disease. Here, we aim to understand the role of different citrin domains and how they contribute to pathogenic mechanisms in citrin deficiency.</div></div><div><h3>Methods</h3><div>We have employed structural modeling and functional reconstitution of purified proteins in proteoliposomes to assess the transport activity and calcium regulation of wild-type citrin and pathogenic variants associated with citrin deficiency. We have also developed a double knockout of citrin and aralar (AGC1), the two paralogs of the mitochondrial aspartate/glutamate carrier, in HAP1 cells to perform mitochondrial imaging and to investigate mitochondrial localisation.</div></div><div><h3>Results</h3><div>Using 33 pathogenic variants of citrin we clarify determinants of subcellular localization and transport mechanism. We identify crucial elements of the carrier domain that are required for transport, including those involved in substrate binding, network formation and dynamics. We show that the N-terminal domain is not involved in calcium regulation of transport, as previously thought, but when mutated causes a mitochondrial import defect.</div></div><div><h3>Conclusions</h3><div>Our work introduces a new role for the N-terminal domain of citrin and demonstrates that dysfunction of the different domains contributes to distinct pathogenic mechanisms in citrin deficiency.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102047"},"PeriodicalIF":7.0,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142470173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Molecular Metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1